In recent years, Allergan, the Ireland-based medical device manufacturer, has found itself at the center of thousands of lawsuits involving its textured breast implants, which have been linked to a rare and serious type of blood cancer. These implants, known as Biocell, have been...
In a landmark decision, the European Commission fined Teva Pharmaceuticals 462.6 million euros for leveraging its dominant position to delay the market entry of competitor treatments for multiple sclerosis (MS). The fine addresses both Teva's manipulation of patent protections and its misleading marketing tactics,...
